These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37921812)

  • 1. Low dose oral minoxidil and the conundrum of cardiovascular complications.
    Ibraheim MK; Elsensohn A; Hauschild C; Hilliard A; Dao H
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Vañó-Galván S; Pirmez R; Hermosa-Gelbard A; Moreno-Arrones ÓM; Saceda-Corralo D; Rodrigues-Barata R; Jimenez-Cauhe J; Koh WL; Poa JE; Jerjen R; Trindade de Carvalho L; John JM; Salas-Callo CI; Vincenzi C; Yin L; Lo-Sicco K; Waskiel-Burnat A; Starace M; Zamorano JL; Jaén-Olasolo P; Piraccini BM; Rudnicka L; Shapiro J; Tosti A; Sinclair R; Bhoyrul B
    J Am Acad Dermatol; 2021 Jun; 84(6):1644-1651. PubMed ID: 33639244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review.
    John JM; Sinclair RD
    Int J Dermatol; 2023 Feb; 62(2):257-259. PubMed ID: 35965281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Gil-Redondo R; Ortega-Quijano D; Fernandez-Nieto D; Jaen-Olasolo P; Vaño-Galvan S
    J Am Acad Dermatol; 2021 Jan; 84(1):222-223. PubMed ID: 32926970
    [No Abstract]   [Full Text] [Related]  

  • 5. Piggyback-acquired hypertrichosis.
    Farsani TT; Kane MJ; Kane KS
    Pediatr Dermatol; 2014; 31(4):520-2. PubMed ID: 24915767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
    Sharma AN; Michelle L; Juhasz M; Muller Ramos P; Atanaskova Mesinkovska N
    Int J Dermatol; 2020 Aug; 59(8):1013-1019. PubMed ID: 32516434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A child with generalized hypertrichosis due to secondary topical minoxidil exposure.
    Maltoni G; Cedirian S; Scozzarella A; Bernardini L; Piraccini BM; Starace M
    Pediatr Dermatol; 2023; 40(4):753-754. PubMed ID: 37042338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hairy fall: syncope resulting from topical application of minoxidil.
    Dubrey SW; VanGriethuysen J; Edwards CM
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26347235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical and oral minoxidil for hair disorders in pediatric patients: What do we know so far?
    Lemes LR; Melo DF; de Oliveira DS; de La-Rocque M; Zompero C; Ramos PM
    Dermatol Ther; 2020 Nov; 33(6):e13950. PubMed ID: 32614119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil.
    Rica Echevarría I; García Del Monte J; Delgado Rubio A; Arcangeli F; Lotti T
    Dermatol Ther; 2020 Nov; 33(6):e14230. PubMed ID: 32844481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile generalized hypertrichosis caused by topical minoxidil.
    Rampon G; Henkin C; de Souza PR; Almeida HL
    An Bras Dermatol; 2016; 91(1):87-8. PubMed ID: 26982785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized hypertrichosis after treatment with topical minoxidil.
    González M; Landa N; Gardeazabal J; Calderón MJ; Bilbao I; Díaz Pérez JL
    Clin Exp Dermatol; 1994 Mar; 19(2):157-8. PubMed ID: 8050148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrichosis in females applying minoxidil topical solution and in normal controls.
    Dawber RP; Rundegren J
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):271-5. PubMed ID: 12702063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minoxidil use in dermatology, side effects and recent patents.
    Rossi A; Cantisani C; Melis L; Iorio A; Scali E; Calvieri S
    Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):130-6. PubMed ID: 22409453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Moreno-Arrones OM; Ortega-Quijano D; Fernandez-Nieto D; Jaen-Olasolo P; Vaño-Galvan S
    Dermatol Ther; 2020 Nov; 33(6):e14106. PubMed ID: 32757405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
    Peluso AM; Misciali C; Vincenzi C; Tosti A
    Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
    Randolph M; Tosti A
    J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    Gupta AK; Talukder M; Williams G
    J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.